At the time of writing, Bluebird bio Inc [BLUE] stock is trading at $0.46, up 2.57%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The BLUE shares have gain 12.40% over the last week, with a monthly amount glided 3.60%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Bluebird bio Inc [NASDAQ: BLUE] stock has seen the most recent analyst activity on November 15, 2024, when JP Morgan downgraded its rating to a Underweight. Previously, BofA Securities downgraded its rating to Neutral on November 15, 2024, and dropped its price target to $0.50. On August 15, 2024, downgrade downgraded it’s rating to Neutral. HSBC Securities downgraded its rating to a Reduce. Morgan Stanley upgraded its rating to a Equal-Weight and raised its price target to $7 on December 08, 2023. In a note dated September 06, 2023, HSBC Securities initiated an Buy rating and provided a target price of $4.21 on this stock.
For the past year, the stock price of Bluebird bio Inc fluctuated between $0.29 and $5.53. Currently, Wall Street analysts expect the stock to reach $14.13 within the next 12 months. Bluebird bio Inc [NASDAQ: BLUE] shares were valued at $0.46 at the most recent close of the market. An investor can expect a potential return of 2971.74% based on the average BLUE price forecast.
Analyzing the BLUE fundamentals
According to Bluebird bio Inc [NASDAQ:BLUE], the company’s sales were 53.12M for trailing twelve months, which represents an -14.36% plunge. Gross Profit Margin for this corporation currently stands at -0.43% with Operating Profit Margin at -5.96%, Pretax Profit Margin comes in at -5.66%, and Net Profit Margin reading is -5.66%. To continue investigating profitability, this company’s Return on Assets is posted at -0.65, Equity is -3.22 and Total Capital is -1.87. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -12.2.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.4298 points at the first support level, and at 0.4044 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.4728, and for the 2nd resistance point, it is at 0.4904.
Ratios To Look Out For
It is important to note that Bluebird bio Inc [NASDAQ:BLUE] has a current ratio of 0.51. In addition, the Quick Ratio stands at 0.33 and the Cash Ratio stands at 0.24. Considering the valuation of this stock, the price to sales ratio is 1.71.
Transactions by insiders
Recent insider trading involved Klima Thomas J, that happened on Sep 30 ’24 when 1006.0 shares were sold. President and CEO, Obenshain Andrew completed a deal on Sep 30 ’24 to sell 34780.0 shares. Meanwhile, Officer Obenshain Andrew bought 34780.0 shares on Sep 30 ’24.
